The joke about riluzole (brand or generic) is not whether it works or not. It is the price, which doubled essentially when the the drug was purchased by Covis. The ludicrous situation is that the generic and brand versions are presently only $200 apart (on a $2,000+/month supply). I think it is a matter of price fixing. Everyone should be furious about this.
Many people don't take the drug. Some cannot safely take it. Others think it may not work. Many think it is not worth the cost.
My husband and I have never encountered a neuromuscular specialist who discouraged its use. They prescribed and insisted on its use (when my husband initially demurred, thinking it would only extend his life 3 months). Different ALS populations were represented in the earliest trials for Rilutek. It is likely more efficacious for some patients than others. The point here is: use of the only drug available for ALS should not be inhibited by price!
My husband was formally diagnosed in March 2010. His liver is fine; his progression is slow. Many of our decisions now are guided by prudence and logistics rather than rapidly cascading symptoms. We have to give some of the credit to Rilutek.
We are fortunate that we can continue to pay for the drug. We will continue to do so while we wait for the next better thing. In the meantime, I feel nothing but contempt for the pharmaceutical companies playing their games on the backs of desperate families.
V